Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fonc.2026.1865670.s002ObjectiveTo design and optimize a health informatics management platform embedded in an official WeChat public account—a widely used social media and messaging application in China—to support chemotherapy-induced myelosuppression (CIM) management and patient self-management among breast cancer patients undergoing chemotherapy.MethodsGuided by a user-centered design approach, the platform was developed and refined in three stages: needs assessment, expert review and iterative refinement, and pilot feasibility testing.ResultsMost patients (88.6%) and clinicians (93.9%) recognized the need for such a platform. In the pilot evaluation, the mean overall MAUQ score was 3.63 ± 0.32, suggesting moderate usability and room for further refinement. During pilot testing, the alert system generated 11 CIM-related alerts and delivered corresponding risk-stratified guidance.ConclusionsThe platform may support personalized CIM management by enabling remote monitoring, automated alerts, and risk-stratified guidance. Further studies with larger samples and longer follow-up are needed to evaluate its effectiveness in improving patient self-management and clinical follow-up efficiency.
Keyword(s):
breast cancer; chemotherapy-induced myelosuppression; health informatics management platform; mHealth; Oncology and Carcinogenesis not elsewhere classified.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)